YHR-1703/YHR-1704
- Generic Name
- YHR-1703/YHR-1704
Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
Phase 3
Completed
- Conditions
- Hypertension and Hyperlipidemia
- Interventions
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 106
- Registration Number
- NCT03103256
- Locations
- 🇰🇷
Seoul Medical Center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath